Sam Huang

Checkpoint Capital L.p.

Assets Managed

$278.651M

Holdings

Last Quarter

2026 - Q1

Filed Date

1mo 6d ago

Growth Rate

-12.94%(2Q avg: -2.85%)

Sustained Growth

0 quarters

Portfolio positions

This chart displays the top 10 holdings in Checkpoint Capital L.p.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 8 positions.

Assets under management

The assets under management (AUM) of Checkpoint Capital L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 278.651M in assets, with a quarterly growth rate of -12.94% and a 2-quarter average growth rate of -2.85%. The portfolio is managed by Sam Huang, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
ARGX Argenx Se - Adr Recent Activity Increased 7.75%	40.1%	$111.728M 153,000 shares@ $730.25 avg price	Increased 7.75%
RYTM Rhythm Pharmaceuticals Inc Recent Activity Increased 23.69%	38.31%	$106.73M 1.227M shares@ $86.97 avg price	Increased 23.69%
RVMD Revolution Medicines Inc Recent Activity Decreased -29.04%	9.17%	$25.532M 262,539 shares@ $97.26 avg price	Decreased -29.04%
IRON Disc Medicine Inc Recent Activity Decreased -36.71%	6.58%	$18.329M 286,661 shares@ $63.94 avg price	Decreased -36.71%
CYTK Cytokinetics Inc Recent Activity Increased 7.9%	4.26%	$11.864M 180,000 shares@ $65.91 avg price	Increased 7.9%
SEPN Septerna Inc Recent Activity New Position	0.87%	$2.41M 100,300 shares@ $24.03 avg price	New Position
CRNX Crinetics Pharmaceuticals In Recent Activity New Position	0.53%	$1.461M 40,230 shares@ $36.33 avg price	New Position
TRVI Trevi Therapeutics Inc Recent Activity New Position	0.22%	$596,500 50,000 shares@ $11.93 avg price	New Position

1-8 of 8